SYMPOSIUM 27

 
11.45-13.15    ROOM N10  
   

Biomarkers 
 
Chairs: Andreas Kribben, Essen, Germany
            Raymond Vanholder, Ghent, Belgium

Uremic toxin profile in AKI versus CKD: any therapeutic implications?
Raymond Vanholder, Ghent, Belgium
NGAL vs KIM-1 vs other biomarkers
Orfeas Liangos, Coburg, Germany
The use of biomarkers in septic AKI
Jill Vanmassenhove, Ghent, Belgium

  

back to the timetable